Page 52 - Encyclopedia of Nursing Research
P. 52

APPLiED RESEARCH  n  19



             informants  reported  memory  loss,  30%  of   with Alzheimer pathology plus clinical diag-
             participants were found not to have a cogni-  noses of dementia.
             tive loss. Among participants in whom fam-   A  review  of  23  studies  of  alcohol  use   A
             ily informants reported no memory loss, 75%   found that alcohol use during adulthood in
             were diagnosed with dementia or cognitive   moderation may protect the individuals from
             impairment.  Mexican  Americans  were  2.2   developing  dementia  in  later  life  (Peters,
             times more likely than European Americans   Peters, Warner, Beckett, & Bulpitt, 2008).
             to  have  MMSE  scores  less  than  24,  indicat-  in conclusion, the findings from a state
             ing cognitive impairment (Watson, Lewis, &   of the science consensus conference on AD
             Fillenbaum, 2005).                       convened by the National institutes of Health
                 Prevention  of  cognitive  decline  has   was recently published (Daviglus et al., 2010).
             ongoing merit for health promotion research.   The  risk  factors  identified  were  current
             Aspects of lifestyle and SES, including diet,   tobacco  use,  apolipoprotein  E  ε4  genotype,
             emotional state, and use of drugs, are of high   and certain medical conditions, which were
             interest  to  nurse  scientists  (Karlamangla   associated  with  increased  risk  (Plassman,
             et al., 2009).                           Williams,  Burke,  Holsinger,  &  Benjamin,
                 Whether or not diabetic Hispanics are at   2010). Although the identification of protec-
             an  increased  risk  for  cognitive  impairment   tive factors was limited, as reported by the
             is  uncertain.  Cognitive  aging  studies  have   authors, the quality of research from obser-
             failed to assess the overall health and phys-  vational studies (N = 122) was low.
             ical  functioning  in  older  subjects.  Recently,   The major outcome from the conference
             investigators  found  decreasing  serum  anti-  was a change in the criteria for diagnosing AD
             oxidant  levels  to  be  negatively  associated   toward an earlier diagnosis using biomarkers,
             with memory performance in a multiethnic   such as brain scans and spinal taps. Another
             sample of elderly (N = 4,809). Hispanic elders’   change is categorizing AD into three stages:
             memory complaints may be misclassified as   preclinical  disease,  mild  cognitive  impair-
             cognitive impairment or dementia with the   ment, and Alzheimer’s dementia. Complaints
             MMSE if other sociodemographic and med-  and  problems  with  everyday  memory  are
             ical conditions such as diabetes are ignored   primary determinants of whether an individ-
             (Perkins et al., 1999; Wu et al., 2003).  ual  seeks  medical  attention  or  is  motivated
                 Data  from  the  Baltimore  Longitudinal   to  participate  in  cognitive  aging  research
             Study  on  Aging  illuminated  the  association   and/or  engage  in  activities  such  as  mental
             between  depression  and  cognitive  decline   stimulation,  social  engagement,  or  lifestyle
             (Bierman, Comijs, Jonker, & Beekman, 2005).   adjustment. The AD research funding at the
             Four groups of individuals were compared: (1)   National  institutes  of  Health  for  fiscal  year
             cognitively normal controls with no Alzheimer   2011 is estimated at $480 million.
             pathology,  (2)  cognitively  normal  individu-
             als  with  Alzheimer  pathology,  (3)  individu-           Graham J. McDougall Jr.
             als  with  mild  cognitive   impairment  plus
             Alzheimer pathology, and (4) individuals with
             clinical diagnoses of dementia plus Alzheimer
             pathology.   Depressive     symptoms   were      APPlied reSeArch
             assessed using the Center for Epidemiologic
             Studies  Depression  Scale.  individuals  with
             Alzheimer  pathology but no cognitive decline   in an attempt to differentiate between vari-
             before death had significantly lower rates of   ous types of research, the scientific commu-
             depression  than  cognitively  normal  controls   nity uses a myriad of terms, which, however,
             with no Alzheimer pathology and individuals   tend to fall into a discrete classification. on
   47   48   49   50   51   52   53   54   55   56   57